Description |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Himmel Pharma |
|
Product Type |
Product Size |
Tablet |
20'S |
Product Company |
Mass Pharma |
Amlodipine 5mg
|
Product Type |
Product Size |
Tablet |
600'S |
Product Company |
Pfizer |
Mefenamic acid 250mg |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
AJM Pharmaceuticals |
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Fresenius kabi |
Cytarabine 500mg/50ml |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Cisplatin 50mg/50ml
|
Content | Etrombopag olamine product ingredient for etrombopag. It is used to treat low blood platelet counts in adults with chronic immune , thrombocytopenia or aplastic anemia. | Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart
| Mefenamic acid is used for the short-term relief of mild to moderate pain from various conditions such as headache, dental pain, menstrual cramps, and muscle aches.Mefenamic acid is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. | Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. | Cytarabine is a medication used in the management and treatment of leukemias and lymphomas. It belongs to the antimetabolic group of medications. This activity reviews the indications, action, and contraindications for cytarabine as a valuable agent in treating acute myeloid leukemia (and other leukemias. | Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas and germ cell tumors.
|
Reviews
There are no reviews yet.